Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Carbamic acid, [2-[[1-[(2,3-dihydro-3-oxospiro[1H-indene-1,4'-piperidin]-1'-yl)carbonyl]- 4-phenylbutyl]amino]-1,1-dimethyl-2-oxoethyl]-, 1,1-dimethylethyl ester, (R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

185526-08-3

Post Buying Request

185526-08-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Carbamic acid, [2-[[1-[(2,3-dihydro-3-oxospiro[1H-indene-1,4'-piperidin]-1'-yl)carbonyl]- 4-phenylbutyl]amino]-1,1-dimethyl-2-oxoethyl]-, 1,1-dimethylethyl ester, (R)-

    Cas No: 185526-08-3

  • Need to discuss

  • No requirement

  • Adequate

  • Weiyel Inc
  • Contact Supplier
  • Carbamic acid, [2-[[1-[(2,3-dihydro-3-oxospiro[1H-indene-1,4'-piperidin]-1'-yl)carbonyl]- 4-phenylbutyl]amino]-1,1-dimethyl-2-oxoethyl]-, 1,1-dimethylethyl ester, (R)-

    Cas No: 185526-08-3

  • Need to discuss

  • No requirement

  • Adequate

  • HANGZHOU TIANYE CHEMICALS CO., LTD.
  • Contact Supplier

185526-08-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185526-08-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,5,2 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 185526-08:
(8*1)+(7*8)+(6*5)+(5*5)+(4*2)+(3*6)+(2*0)+(1*8)=153
153 % 10 = 3
So 185526-08-3 is a valid CAS Registry Number.

185526-08-3Downstream Products

185526-08-3Relevant articles and documents

The synthesis and activity of spiroindane growth hormone secretagogues

Tata, James R.,Nargund, Ravi P.,Murphy, Marcia M.,Johnston, David B. R.,Patchett, Arthur A.,Cheng, Kang,Wei, Liente,Chan, Wanda W.-S.,Butler, Bridget,Jacks, Thomas M.,Hickey, Gerard,Smith, Roy

, p. 663 - 668 (2007/10/03)

The synthesis and activities of a series of spiroindane growth hormone secretagogues is reported. Modification of the benzylic position of the spiroindane has resulted in a dramatic increase in potency resulting in subnanomolar peptidomimetic growth hormone secretagogues. In vivo data demonstrating the good oral activity of these analogs is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 185526-08-3